Search
for
Sort by
Research 181–210 of 536
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Mechanisms of autophagy and their implications in dermatological disorders
- Review of Promising Off-Label Use of Deucravacitinib
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- Tertiary Lymphoid Organs at the Center Stage of Skin's Humoral Immunity
- Chronic graft versus host disease and skin
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
- Volatile organic compounds: A proinflammatory activator in autoimmune diseases
- Cytokine Engineering Approaches for Regenerative Medicine
- Clinical Applications of Extracellular Vesicles: Promises and Pitfalls
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- JAK inhibition decreases the autoimmune burden in Down syndrome
- JAK inhibition decreases the autoimmune burden in Down syndrome
- The Efficacy and Psychoneuroimmunology Mechanism of Camouflage Combined With Psychotherapy in Vitiligo Treatment
- Alopecia Areata in the Elderly: A 10-Year Retrospective Study
- Pathological sequelae of long-haul COVID
- The Human Skin Microbiome in Selected Cutaneous Diseases
- Vitiligo—Current Treatment Options and Future Perspectives
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Vitamin D status in scarring and nonscarring alopecia
- Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- Efficacy of diphenylcyclopropenone in alopecia areata: a comparison of two treatment regimens
- Alopecia areata: current concepts
- Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation
- Alopecia Areata: An Updated Review for 2023
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies